WallStreetZenWallStreetZen

NASDAQ: SWAV
Shockwave Medical Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SWAV past earnings growth

How has SWAV's earnings growth performed historically?
Company
-33.39%
Industry
88.19%
Market
104.85%
SWAV's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SWAV's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

SWAV past revenue growth

How has SWAV's revenue growth performed historically?
Company
49.11%
Industry
9.25%
Market
17.15%
SWAV's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SWAV's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SWAV's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SWAV earnings and revenue history

Current Revenue
$730.2M
Current Earnings
$147.3M
Current Profit Margin
20.2%

SWAV Return on Equity

Current Company
24%
Current Industry
10.5%
Current Market
188%
SWAV's Return on Equity (24%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SWAV announces earnings.

SWAV Return on Assets

Current Company
12.8%
Current Industry
5.3%
SWAV is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SWAV Return on Capital Employed

Current Company
12.39%
Current Industry
8.3%
SWAV has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SWAV vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SWAV$730.23M$194.70M$147.28M+126.45%-33.39%
PODD$1.70B$323.60M$206.30M+24.66%+118.09%
BRKR$2.96B$659.80M$427.20M+9.36%+20.49%
SNN$5.55B$1.11B$263.00M+2.50%-16.85%
BIO$2.67B-$800.67M-$637.32M+3.13%N/A
View Top Medical Device Stocks

SWAV earnings dates

Next earnings date
May 6, 2024

Shockwave Medical Earnings & Revenue FAQ

What were SWAV's earnings last quarter?

On Invalid Date, Shockwave Medical (NASDAQ: SWAV) reported Q4 2023 earnings per share (EPS) of $1.20, up 69.39% year over year. Total Shockwave Medical earnings for the quarter were $44.31 million. In the same quarter last year, Shockwave Medical's earnings per share (EPS) was $3.92.

If you're new to stock investing, here's how to buy Shockwave Medical stock.

What was SWAV's earnings growth in the past year?

As of Q2 2024, Shockwave Medical's earnings has grown -33.39% year over year. This is 121.58 percentage points lower than the US Medical Devices industry earnings growth rate of 88.19%. Shockwave Medical's earnings in the past year totalled $147.28 million.

What is SWAV's earnings date?

Shockwave Medical's earnings date is Invalid Date. Add SWAV to your watchlist to be reminded of SWAV's next earnings announcement.

What was SWAV's revenue last quarter?

On Invalid Date, Shockwave Medical (NASDAQ: SWAV) reported Q4 2023 revenue of $202.98 million up 40.93% year over year. In the same quarter last year, Shockwave Medical's revenue was $144.03 million.

What was SWAV's revenue growth in the past year?

As of Q2 2024, Shockwave Medical's revenue has grown 49.11% year over year. This is 39.85 percentage points higher than the US Medical Devices industry revenue growth rate of 9.25%. Shockwave Medical's revenue in the past year totalled $730.23 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.